Some new chemo: There have been recent presentations at the 2013 asco meeting that have examined combination therapy with Abraxane + gemcitabine that demonstrated that this combination had a statistically improved survival (median=8.5 months) vs gemcitabine alone (median=6.7 months). There is also the chemo combination (folfirinox) which is older and more toxic but has a median survival of 11.1months).
Answered 6/24/2014
4.9k views
Cyberknife: Aggressive local treatment in addition to chemotherapy has offered good palliation of the symptoms and improvement of local control. Use of cyberknife radiosurgery in elderly with advanced pancreatic cancer patients is usually very well tolerated and improves local control and can offer palliation if patient is symptomatic. Gemzar (gemcitabine) alone or in combination with 5-fu mainstay of systemic therapy.
Answered 12/19/2017
4.9k views
2 doctors weighed in across 2 answers
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
7 doctors weighed in across 4 answers
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question